Top compounds associated with response to RNF34


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel GDSC1000 pan-cancer AAC -0.14 6e-05
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA CHIR-99021 GDSC1000 pan-cancer AAC -0.13 0.0001
mRNA SNX-2112 CTRPv2 pan-cancer AAC 0.12 0.0002
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.14 0.0002
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.13 0.0006
mRNA Irinotecan CCLE pan-cancer AAC 0.2 0.0006
mRNA dabrafenib GDSC1000 pan-cancer AAC -0.11 0.001
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.001
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.12 0.001
Download CSV